ALFA Filings
Every announcement, straight from the exchange
Every Rubicon Research business update announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.
Rubicon Research reported the conclusion of a US FDA inspection at its Satara facility. The audit yielded one procedural observation unrelated to data integrity.